Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea.

Weinstock TG, Wang X, Rueschman M, Ismail-Beigi F, Aylor J, Babineau DC, Mehra R, Redline S.

Sleep. 2012 May 1;35(5):617-625B. doi: 10.5665/sleep.1816.

2.

A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea.

Salord N, Fortuna AM, Monasterio C, Gasa M, Pérez A, Bonsignore MR, Vilarrasa N, Montserrat JM, Mayos M.

Sleep. 2016 Jan 1;39(1):35-41. doi: 10.5665/sleep.5312.

3.

Eight Hours of Nightly Continuous Positive Airway Pressure Treatment of Obstructive Sleep Apnea Improves Glucose Metabolism in Patients with Prediabetes. A Randomized Controlled Trial.

Pamidi S, Wroblewski K, Stepien M, Sharif-Sidi K, Kilkus J, Whitmore H, Tasali E.

Am J Respir Crit Care Med. 2015 Jul 1;192(1):96-105. doi: 10.1164/rccm.201408-1564OC.

4.

Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study.

Egea CJ, Aizpuru F, Pinto JA, Ayuela JM, Ballester E, Zamarrón C, Sojo A, Montserrat JM, Barbe F, Alonso-Gomez AM, Rubio R, Lobo JL, Duran-Cantolla J, Zorrilla V, Nuñez R, Cortés J, Jiménez A, Cifrián J, Ortega M, Carpizo R, Sánchez A, Terán J, Iglesias L, Fernández C, Alonso ML, Cordero J, Roig E, Pérez F, Muxi A, Gude F, Amaro A, Calvo U, Masa JF, Utrabo I, Porras Y, Lanchas I, Sánchez E; Spanish Group of Sleep Breathing Disorders.

Sleep Med. 2008 Aug;9(6):660-6. Epub 2007 Sep 27.

PMID:
17904420
5.

Glucose tolerance and cardiovascular risk biomarkers in non-diabetic non-obese obstructive sleep apnea patients: Effects of long-term continuous positive airway pressure.

Monneret D, Tamisier R, Ducros V, Faure P, Halimi S, Baguet JP, Lévy P, Pépin JL, Borel AL.

Respir Med. 2016 Mar;112:119-25. doi: 10.1016/j.rmed.2016.01.015. Epub 2016 Jan 28.

PMID:
26847407
6.

CPAP for the metabolic syndrome in patients with obstructive sleep apnea.

Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A.

N Engl J Med. 2011 Dec 15;365(24):2277-86. doi: 10.1056/NEJMoa1103944. Retraction in: Sharma SK, Agrawal S, Damodaran D, Sreenivas V, Kadhiravan T, Lakshmy R, Jagia P, Kumar A. N Engl J Med. 2013 Oct 31;369(18):1770.

7.

Diagnosis and initial management of obstructive sleep apnea without polysomnography: a randomized validation study.

Mulgrew AT, Fox N, Ayas NT, Ryan CF.

Ann Intern Med. 2007 Feb 6;146(3):157-66.

PMID:
17283346
8.

Cardiometabolic changes after continuous positive airway pressure for obstructive sleep apnoea: a randomised sham-controlled study.

Hoyos CM, Killick R, Yee BJ, Phillips CL, Grunstein RR, Liu PY.

Thorax. 2012 Dec;67(12):1081-9. doi: 10.1136/thoraxjnl-2011-201420. Epub 2012 May 5. Erratum in: Thorax. 2013 Sep;68(9):879.

PMID:
22561530
9.

Oral appliance versus continuous positive airway pressure in obstructive sleep apnea syndrome: a 2-year follow-up.

Doff MH, Hoekema A, Wijkstra PJ, van der Hoeven JH, Huddleston Slater JJ, de Bont LG, Stegenga B.

Sleep. 2013 Sep 1;36(9):1289-96. doi: 10.5665/sleep.2948.

10.

The complex sleep apnea resolution study: a prospective randomized controlled trial of continuous positive airway pressure versus adaptive servoventilation therapy.

Morgenthaler TI, Kuzniar TJ, Wolfe LF, Willes L, McLain WC 3rd, Goldberg R.

Sleep. 2014 May 1;37(5):927-34. doi: 10.5665/sleep.3662.

11.
12.

Auto-adjusting positive airway pressure treatment for sleep apnea diagnosed by home sleep testing.

Berry RB, Sriram P.

J Clin Sleep Med. 2014 Dec 15;10(12):1269-75. doi: 10.5664/jcsm.4272.

13.

[Effect of CPAP therapy on dynamic glucose level in OSAHS patients with newly diagnosed T2DM].

Zhao L, Hui P, Xie Y, Hou Y, Wei X, Ma W, Wang J, Zhou L, Zhang W.

Zhonghua Yi Xue Za Zhi. 2015 Nov 24;95(44):3579-83. Chinese.

PMID:
26813368
14.

Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial.

Phillips CL, Grunstein RR, Darendeliler MA, Mihailidou AS, Srinivasan VK, Yee BJ, Marks GB, Cistulli PA.

Am J Respir Crit Care Med. 2013 Apr 15;187(8):879-87. doi: 10.1164/rccm.201212-2223OC.

15.
16.

Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study.

Martínez-García MA, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Román-Sánchez P, Illa FB, Canal JM, Durán-Cantolla J.

Am J Respir Crit Care Med. 2009 Jul 1;180(1):36-41. doi: 10.1164/rccm.200808-1341OC. Epub 2009 Apr 30.

PMID:
19406983
17.

Effects of nasal CPAP treatment on insulin resistance, lipid profile, and plasma leptin in sleep apnea.

Cuhadaroğlu C, Utkusavaş A, Oztürk L, Salman S, Ece T.

Lung. 2009 Mar-Apr;187(2):75-81. doi: 10.1007/s00408-008-9131-5. Epub 2009 Jan 7.

PMID:
19127383
19.
20.

Supplemental Content

Support Center